Warning: The NCBI web site requires JavaScript to function. more...
Of mice and humans: how good are HLA transgenic mice as a model of human immune responses?
Kotturi MF, Assarsson E, Peters B, Grey H, Oseroff C, Pasquetto V, Sette A.
Immunome Res. 2009 Jun 17;5:3.
Related citations
Highly conserved pattern of recognition of influenza A wild-type and variant CD8+ CTL epitopes in HLA-A2+ humans and transgenic HLA-A2+/H2 class I-deficient mice.
Hu N, D'Souza C, Cheung H, Lang H, Cheuk E, Chamberlain JW.
Vaccine. 2005 Nov 1;23(45):5231-44. Epub 2005 Jul 25.
Human MHC class I transgenic mice deficient for H2 class I expression facilitate identification and characterization of new HLA class I-restricted viral T cell epitopes.
Cheuk E, D'Souza C, Hu N, Liu Y, Lang H, Chamberlain JW.
J Immunol. 2002 Nov 15;169(10):5571-80.
A novel mouse model for evaluation and prediction of HLA-A2-restricted CEA cancer vaccine responses.
Conforti A, Peruzzi D, Giannetti P, Biondo A, Ciliberto G, La Monica N, Aurisicchio L.
J Immunother. 2009 Sep;32(7):744-54.
Identification of major epitopes of Mycobacterium tuberculosis AG85B that are recognized by HLA-A*0201-restricted CD8+ T cells in HLA-transgenic mice and humans.
Geluk A, van Meijgaarden KE, Franken KL, Drijfhout JW, D'Souza S, Necker A, Huygen K, Ottenhoff TH.
J Immunol. 2000 Dec 1;165(11):6463-71.
Optimization and immune recognition of multiple novel conserved HLA-A2, human immunodeficiency virus type 1-specific CTL epitopes.
Corbet S, Nielsen HV, Vinner L, Lauemoller S, Therrien D, Tang S, Kronborg G, Mathiesen L, Chaplin P, Brunak S, Buus S, Fomsgaard A.
J Gen Virol. 2003 Sep;84(Pt 9):2409-21.
CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
J Immunol. 1995 Mar 15;154(6):2733-42.
Protection against lethal vaccinia virus challenge in HLA-A2 transgenic mice by immunization with a single CD8+ T-cell peptide epitope of vaccinia and variola viruses.
Snyder JT, Belyakov IM, Dzutsev A, Lemonnier F, Berzofsky JA.
J Virol. 2004 Jul;78(13):7052-60.
Response of established human breast tumors to vaccination with mammaglobin-A cDNA.
Narayanan K, Jaramillo A, Benshoff ND, Campbell LG, Fleming TP, Dietz JR, Mohanakumar T.
J Natl Cancer Inst. 2004 Sep 15;96(18):1388-96.
Strong memory CD8+ T cell responses against immunodominant and three new subdominant HLA-B27-restricted influenza A CTL epitopes following secondary infection of HLA-B27 transgenic mice.
Cheuk E, Chamberlain JW.
Cell Immunol. 2005 Apr;234(2):110-23.
Cytotoxic T cell responses in HLA-A2.1 transgenic mice. Recognition of HLA alloantigens and utilization of HLA-A2.1 as a restriction element.
Le AX, Bernhard EJ, Holterman MJ, Strub S, Parham P, Lacy E, Engelhard VH.
J Immunol. 1989 Feb 15;142(4):1366-71.
HLA-A2.1/K(b) transgenic murine dendritic cells transduced with an adenovirus encoding human gp100 process the same A2.1-restricted peptide epitopes as human antigen-presenting cells and elicit A2.1-restricted peptide-specific CTL.
Yang S, Linette GP, Longerich S, Roberts BL, Haluska FG.
Cell Immunol. 2000 Aug 25;204(1):29-37.
Influenza A-specific, HLA-A2.1-restricted cytotoxic T lymphocytes from HLA-A2.1 transgenic mice recognize fragments of the M1 protein.
Engelhard VH, Lacy E, Ridge JP.
J Immunol. 1991 Feb 15;146(4):1226-32.
Generation of human cytotoxic T cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine.
Tsang KY, Zaremba S, Nieroda CA, Zhu MZ, Hamilton JM, Schlom J.
J Natl Cancer Inst. 1995 Jul 5;87(13):982-90.
Derivation of HLA-B*0702 transgenic mice: functional CTL repertoire and recognition of human B*0702-restricted CTL epitopes.
Alexander J, Oseroff C, Sidney J, Sette A.
Hum Immunol. 2003 Feb;64(2):211-23.
Human immunodeficiency virus type 1 Nef epitopes recognized in HLA-A2 transgenic mice in response to DNA and peptide immunization.
Sandberg JK, Leandersson AC, Devito C, Kohleisen B, Erfle V, Achour A, Levi M, Schwartz S, Kärre K, Wahren B, Hinkula J.
Virology. 2000 Jul 20;273(1):112-9.
Protective immunity provided by HLA-A2 epitopes for fusion and hemagglutinin proteins of measles virus.
Oh S, Stegman B, Pendleton CD, Ota MO, Pan CH, Griffin DE, Burke DS, Berzofsky JA.
Virology. 2006 Sep 1;352(2):390-9. Epub 2006 Jun 15.
Clearance of Chlamydia pneumoniae infection in H-2 class I human leucocyte antigen-A2.1 monochain transgenic mice.
Tammiruusu A, Haveri A, Pascolo S, Lahesmaa R, Stevanovic S, Rammensee HG, Sarvas M, Puolakkainen M, Vuola JM.
Scand J Immunol. 2005 Aug;62(2):131-9.
In vivo induction of cellular and humoral immune responses by hybrid DNA vectors encoding simian/human immunodeficiency virus/hepatitis B surface antigen virus particles in BALB/c and HLA-A2-transgenic mice.
Marsac D, Puaux AL, Rivière Y, Michel ML.
Immunobiology. 2005;210(5):305-19.
Generation of human tumor-specific CTLs in HLA-A2.1-transgenic mice using unfractionated peptides from eluates of human primary breast and ovarian tumors.
Gritzapis AD, Sotiriadou NN, Papamichail M, Baxevanis CN.
Cancer Immunol Immunother. 2004 Nov;53(11):1027-40. Epub 2004 May 26.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on